Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EMEA grants orphan medicinal product designation to picoplatin for SCLC

Oct. 24, 2007

Preclinical toxicology program for DTS-108 initiated at Diatos

Oct. 24, 2007

Taxotere receives positive opinion in the E.U. for head and neck cancer

Oct. 23, 2007

Tarceva approved for lung cancer patients in Japan

Oct. 23, 2007

In vivo antitumor activity of meriolin-3, a novel CDK inhibitor

Oct. 23, 2007

Agreement to develop Erbitux for mCRC in Japan

Oct. 23, 2007

Abraxis BioScience's Abraxane receives positive opinion in Europe

Oct. 22, 2007

Pharmion initiates pivotal phase III amrubicin study in small cell lung cancer

Oct. 22, 2007

Phase I testing commences for SAR-3419 in non-Hodgkin's lymphoma

Oct. 22, 2007

New therapeutic options for cancer imparted in recent patents

Oct. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...